SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss
· inc.com · popularity 18/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at inc.com →
Summary
SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.
Found in: Inc.. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 10.